U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H14NO.I
Molecular Weight 267.1073
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FURTRETHONIUM IODIDE

SMILES

[I-].C[N+](C)(C)CC1=CC=CO1

InChI

InChIKey=YKASHPSKFYVZRC-UHFFFAOYSA-M
InChI=1S/C8H14NO.HI/c1-9(2,3)7-8-5-4-6-10-8;/h4-6H,7H2,1-3H3;1H/q+1;/p-1

HIDE SMILES / InChI
Molecular Formula HI
Molecular Weight 127.9124
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C8H14NO
Molecular Weight 140.2029
Charge 1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

FURTRETHONIUM is an agonist of muscarinic acetylcholine receptors. It was used for the treatment of glaucoma.

Approval Year

1944
15
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8429
Furmethide

Approved Use

Furtrethonum is a parasympathomimetic drug used for the treatment of glaucoma
Doses

Doses

DosePopulationAdverse events​
10 % 1 times / day multiple, ophthalmic
Dose: 10 %, 1 times / day
Route: ophthalmic
Route: multiple
Dose: 10 %, 1 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14829485
unhealthy
n = 21
Health Status: unhealthy
Condition: glaucoma
Population Size: 21
Sources:
https://pubmed.ncbi.nlm.nih.gov/14829485
Disc. AE: Dacryostenosis acquired...
AEs leading to
discontinuation/dose reduction:
Dacryostenosis acquired (71%)
Sources:
https://pubmed.ncbi.nlm.nih.gov/14829485
AEs

AEs

AESignificanceDosePopulation
Dacryostenosis acquired 71%
Disc. AE
10 % 1 times / day multiple, ophthalmic
Dose: 10 %, 1 times / day
Route: ophthalmic
Route: multiple
Dose: 10 %, 1 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/14829485
unhealthy
n = 21
Health Status: unhealthy
Condition: glaucoma
Population Size: 21
Sources:
https://pubmed.ncbi.nlm.nih.gov/14829485
Sourcing

Sourcing

Vendor/AggregatorIDURL
ABI Chem
AC1L1W9Q
BOC Sciences
541-64-0
ChemMol
99154117
http://www.chemmol.com/chemmol/99154117.html
Enamine
BBV-82745797
Enamine
EN300-1588178
MolPort
MolPort-006-111-713
NCI Plated 2007
27126
NCI Plated 2007
44407
NovoSeek
10938
ZINC
ZINC000000001500
http://zinc15.docking.org/substances/ZINC000000001500
eMolecules
109817126
PubMed

PubMed

TitleDatePubMed
Further studies on the use of furmethide in the treatment of glaucoma.
1946 Apr
The use of furmethide in comparison with pilocarpine and eserine for the treatment of glaucoma.
1947 Aug
Glaucoma treatment by furnethide and diisopropylfluorophosphate.
1949 Jul
Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
1997 Jul
Patents

Patents

JP2002105045A
7
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:15:53 UTC 2023
Edited
by admin
on Fri Dec 15 16:15:53 UTC 2023
Record UNII
1D064NLD7G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FURTRETHONIUM IODIDE
INN   MI  
INN  
Official Name English
FURANOL
Systematic Name English
2-FURANMETHANAMINIUM, N,N,N-TRIMETHYL-, IODIDE
Systematic Name English
FURTRETHONIUM IODIDE [MI]
Common Name English
furtrethonium iodide [INN]
Common Name English
FURFURYLTRIMETHYL AMMONIUM IODIDE
Systematic Name English
2-FURANMETHANAMINIUM, N,N,N-TRIMETHYL-, IODIDE (1:1)
Systematic Name English
TRIMETHYLFURFURYLAMMONIUM IODIDE
Systematic Name English
FURAMON
Brand Name English
FURMETHIDE IODIDE
Brand Name English
NSC-27126
Code English
AMMONIUM, FURFURYLTRIMETHYL-, IODIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C47796
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
Code System Code Type Description
INN
133
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
FDA UNII
1D064NLD7G
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
ChEMBL
CHEMBL2110739
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
NSC
27126
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
EVMPD
SUB07854MIG
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
CAS
541-64-0
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
EPA CompTox
DTXSID60968970
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
MERCK INDEX
m5611
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY Merck Index
NCI_THESAURUS
C76041
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
PUBCHEM
10937
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
ECHA (EC/EINECS)
208-789-5
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
SMS_ID
100000084486
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
MESH
C028530
Created by admin on Fri Dec 15 16:15:53 UTC 2023 , Edited by admin on Fri Dec 15 16:15:53 UTC 2023
PRIMARY
Related Record Type Details
Structure of FURTRETHONIUM
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of FURTRETHONIUM
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966